* Bank of America, Wells Fargo gain; Goldman falls
* Health stocks up for 6th session, Illumina leads
* Donald Trump to hold press conference on Wednesday
* Dow down 0.14 pct, S&P up 0.04 pct, Nasdaq up 0.25 pct
(Adds details, updates prices)
By Yashaswini Swamynathan
Jan 10 The Nasdaq hit a record intraday high on
Tuesday, extending its run as healthcare stocks rose for the
sixth straight session, while a jump in banks lifted the S&P
The Dow, however, was weighed down by a 1.8 percent decline
in IBM and a 0.7 percent loss in Goldman Sachs.
Investors are focusing on the earnings season, which kicks
off this week, to assess whether fourth-quarter corporate
performance justifies Wall Street's record levels.
"We've shifted from that exuberance post the election and
the rotation into some of the sectors and now we are entering a
wait-and-see mode with earnings knocking at the front door,"
said Art Hogan, chief market strategist at Wunderlich Equity
Capital Markets in News York.
"Earnings may be the pivot to move things higher."
S&P 500 companies are set to post their strongest quarterly
growth in three years, with earnings estimated to have risen 5.8
percent in the fourth quarter, mainly driven by financials,
according to Thomson Reuters I/B/E/S.
At 14:06 p.m. ET (1906 GMT), the Dow Jones Industrial
Average was down 27.85 points, or 0.14 percent, at
19,859.53 and the S&P 500 was up 1.11 points, or 0.04
percent, at 2,270.01.
The Nasdaq Composite was up 13.88 points, or 0.25
percent, at 5,545.70, easing from a life high of 5,564.25 - its
third straight record since Friday.
Seven of the 11 major S&P sectors were higher, led by a 0.76
percent gain in financials.
JPMorgan, Bank of America and Wells Fargo
scheduled to report results on Friday. Bank of America
and Wells Fargo were up about 2 percent.
Healthcare stocks gained 0.62 percent and the
Nasdaq biotech index was 0.75 percent higher, both up for
the sixth session in a row.
General Motors rose 3.7 percent to $37.38 after the
No.1 U.S. automaker forecast 2017 profit above analysts'
Illumina surged 17.4 percent to $166.08 after the
diagnostics company gave a strong quarterly forecast and
launched a new product.
Zimmer Biomet rose 6.6 percent to $114.07 after the
orthopedics company said it expects fourth-quarter net sales
well above analysts' expectations.
Advancing issues outnumbered decliners on the NYSE by 1,747
to 1,137. On the Nasdaq, 1,716 issues rose and 1,085 fell.
The S&P 500 index showed 11 new 52-week highs and no new
lows, while the Nasdaq recorded 74 new highs and 17 new lows.
(Reporting by Yashaswini Swamynathan in Bengaluru; Editing by
Savio D'Souza and Saumyadeb Chakrabarty)